The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Dec. 09, 2022
Applicant:
Intellia Therapeutics, Inc., Cambridge, MA (US);
Inventors:
Arti Mahendra Prakash Kanjolia, Malden, MA (US);
Shobu Odate, Arlington, MA (US);
Jessica Lynn Seitzer, Windham, NH (US);
Reynald Michael Lescarbeau, Medford, MA (US);
Walter Strapps, Dedham, MA (US);
Assignee:
Intellia Therapeutics, Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 9/22 (2006.01); A61P 25/28 (2006.01); C12N 15/10 (2006.01); A61K 48/00 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61P 25/28 (2018.01); C12N 9/22 (2013.01); C12N 15/102 (2013.01); A61K 48/00 (2013.01); A61K 48/0091 (2013.01); C12N 15/111 (2013.01); C12N 2310/20 (2017.05); C12N 2310/321 (2013.01); C12N 2800/80 (2013.01);
Abstract
Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.